◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

RICH PHARMACEUTICALS, INC.

CIK: 1504389 SIC: 2834
-
Revenue
$-1.69M
Net Income
-
Gross Margin
-
Op. Margin
$-978.34K
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 7 annual reports available (2011 - 2017)
Breakdown TTM
(Mar 31, 2018)
FY 2017
(Mar 31, 2018)
FY 2016
(Mar 31, 2017)
FY 2015
(Mar 31, 2016)
FY 2014
(Mar 31, 2015)
FY 2013
(Mar 31, 2014)
+ Total Revenue - $115.00K - - - -
Revenue Growth % nan% nan% nan% nan% nan% nan%
Cost of Revenue - - $45.55K $16.00K $200.93K $335.00K
+ Gross Profit - - - - $-200.93K $-335.00K
Gross Margin % nan% nan% nan% nan% nan% nan%
Operating Expenses $1.45M $1.45M $951.82K $1.12M $3.61M $3.00M
Research & Development $332.63K $332.63K $71.93K $16.82K $165.37K $123.80K
+ Operating Income $-1.34M $-1.34M $-951.82K $-1.12M $-3.61M $-3.00M
Operating Margin % nan% -1162.1% nan% nan% nan% nan%
Interest Expense $-663.63K $-663.63K $-224.83K $-185.14K $-56.53K $342.00
Other Income/Expense - $-355.95K $-2.29M - - -
+ Net Income $-1.69M $-1.69M $-3.24M $-1.77M $-4.13M $-3.00M
Net Margin % nan% -1471.6% nan% nan% nan% nan%
Breakdown FY 2017
(Mar 31, 2018)
FY 2016
(Mar 31, 2017)
FY 2015
(Mar 31, 2016)
FY 2014
(Mar 31, 2015)
FY 2013
(Mar 31, 2014)
Cash & Cash Equivalents $6.22K $40.90K - $15.89K $12.39K
Other Current Assets - - $2.80K $7.58K $1.56K
Total Current Assets $24.52K $50.90K $2.80K $23.47K $13.95K
Property Plant & Equipment $913.00 $2.12K $3.73K $788.00 $1.26K
Total Assets $37.43K $53.03K $6.53K $24.26K $15.21K
Accounts Payable $327.15K $349.63K $1.14M $910.27K $180.67K
Accrued Liabilities $1.84M $937.78K $530.15K $200.89K $451.29K
Total Current Liabilities $6.40M $5.38M $2.40M $1.66M $852.51K
Total Liabilities $6.40M $5.38M $2.40M $1.74M $852.51K
Common Stock $1.71M $101.45K $216.36K $1.54M $414.41K
Retained Earnings $-14.14M $-12.44M $-9.20M $-7.43M $-3.30M
Total Stockholders Equity $-6.36M $-5.33M $-2.39M $-1.72M $-837.30K
Total Liabilities & Equity $37.43K $53.03K $6.53K $24.26K $15.21K
Breakdown TTM
(Mar 31, 2018)
FY 2017
(Mar 31, 2018)
FY 2016
(Mar 31, 2017)
FY 2015
(Mar 31, 2016)
FY 2014
(Mar 31, 2015)
FY 2013
(Mar 31, 2014)
Net Income $-4.50M $-1.69M $-3.24M $-1.77M $-4.13M $-3.00M
Stock-based Compensation - - $48.02K $241.00K $866.13K $1.87M
Change in Payables $818.66K $371.46K $110.20K $229.16K $729.60K $173.97K
Operating Cash Flow $-978.34K $-508.48K $-553.39K $-495.10K $-1.45M $-342.83K
Capital Expenditure - - - - - $1.42K
Investing Cash Flow $-42.90K $-17.30K $-10.00K $-3.74K - $-46.42K
Financing Cash Flow $933.43K $491.10K $604.30K $482.95K $1.45M $400.05K
Net Change in Cash $-87.81K $-34.68K $40.90K $-15.89K $3.50K $10.80K
SEC Filing Format - Data shown as it appears in the Q3 2017 (10-Q) filing Period ended: Dec 31, 2017
Condensed Consolidated Statements of Operations
Description Dec 31, 2017 Dec 31, 2017
Current Prior Year Current YTD Prior Year YTD
Total Revenue - - $115.00K -
Cost of Revenue $21.62K $10.32K $121.62K $26.40K
Operating Expenses $333.72K $208.82K $1.14M $607.09K
Research & Development $92.75K - $241.16K -
Operating Income $-333.72K $-208.82K $-1.02M $-607.09K
Interest Expense $-50.01K $-43.72K $-218.69K $-186.19K
Other Income/Expense $389.07K $-331.63K $571.37K $-378.24K
Net Income $55.35K $-540.45K $-450.29K $-985.33K
Condensed Consolidated Balance Sheets
Description Dec 31, 2017 Mar 31, 2017
Cash & Cash Equivalents $3.74K $40.90K
Total Current Assets $19.04K $50.90K
Property Plant & Equipment $1.23K $2.12K
Total Assets $35.27K $53.03K
Accounts Payable $352.11K $296.63K
Accrued Liabilities $1.36M $937.78K
Total Current Liabilities $5.25M $5.38M
Total Liabilities $5.25M $5.38M
Common Stock $955.02K $101.45K
Retained Earnings $-12.90M $-12.44M
Total Stockholders Equity $-5.21M $-5.33M
Total Liabilities & Equity $35.27K $53.03K
Condensed Consolidated Statements of Cash Flows
Description Dec 31, 2017 Dec 31, 2017
Current Prior Year Current YTD Prior Year YTD
Net Income $55.35K $-540.45K $-450.29K $-985.33K
Change in Payables - - $379.42K $127.13K
Operating Cash Flow - - $-369.65K $-288.93K
Investing Cash Flow - - $-20.30K -
Financing Cash Flow - - $352.79K $288.93K
Net Change in Cash - - $-37.16K -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...